SE8203878L - Antiviruskomposition - Google Patents

Antiviruskomposition

Info

Publication number
SE8203878L
SE8203878L SE8203878A SE8203878A SE8203878L SE 8203878 L SE8203878 L SE 8203878L SE 8203878 A SE8203878 A SE 8203878A SE 8203878 A SE8203878 A SE 8203878A SE 8203878 L SE8203878 L SE 8203878L
Authority
SE
Sweden
Prior art keywords
group
denotes
atom
hydrogen atom
methyl group
Prior art date
Application number
SE8203878A
Other languages
English (en)
Other versions
SE8203878D0 (sv
Inventor
E Mochida
Y Suzuki
K Yamaguch
H Ohnishi
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56096376A external-priority patent/JPS58914A/ja
Priority claimed from JP57075782A external-priority patent/JPS58192820A/ja
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of SE8203878D0 publication Critical patent/SE8203878D0/sv
Publication of SE8203878L publication Critical patent/SE8203878L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8203878A 1981-06-22 1982-06-22 Antiviruskomposition SE8203878L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56096376A JPS58914A (ja) 1980-11-10 1981-06-22 抗ウイルス作用を有する医薬組成物
JP57075782A JPS58192820A (ja) 1982-05-06 1982-05-06 抗ウイルス作用を有する医薬組成物

Publications (2)

Publication Number Publication Date
SE8203878D0 SE8203878D0 (sv) 1982-06-22
SE8203878L true SE8203878L (sv) 1982-12-23

Family

ID=26416933

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8203878A SE8203878L (sv) 1981-06-22 1982-06-22 Antiviruskomposition

Country Status (4)

Country Link
EP (1) EP0132540A1 (sv)
AU (1) AU533742B2 (sv)
NL (1) NL8220205A (sv)
SE (1) SE8203878L (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) * 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3112337A (en) * 1960-05-09 1963-11-26 Parke Davis & Co 4-halo-3-sulfamoylbenzoic acid esters
FR1311859A (fr) * 1961-09-18 1962-12-14 Soc Ind Fab Antibiotiques Sifa Nouveaux dérivés des sulfamides, et procédé de préparation
GB1353357A (en) * 1970-09-14 1974-05-15 Pfizer Substituted 5-sulphamylbenzoic acids
GB1458029A (en) * 1972-12-26 1976-12-08 Pfizer Sulphamylbenzoic acids and preparation thereof
JPS5817167B2 (ja) * 1980-11-10 1983-04-05 持田製薬株式会社 抗ウイルス作用を有する医薬組成物
SE8203877L (sv) * 1981-06-22 1982-12-23 Hodogaya Chemical Co Ltd Aminosulfonylbensoesyraderivat

Also Published As

Publication number Publication date
AU533742B2 (en) 1983-12-08
NL8220205A (nl) 1983-05-02
EP0132540A1 (en) 1985-02-13
SE8203878D0 (sv) 1982-06-22
AU8509782A (en) 1983-01-06

Similar Documents

Publication Publication Date Title
ES436124A1 (es) Un procedimiento para la preparacion de derivados de pira- zol.
DK283589A (da) 1-indolylalkyl-4-(substitueret pyridinyl)-piperaziner
DK157861C (da) Analogifremgangsmaade til fremstilling af 4-substituerede fenylalkylimidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf
FI823897A0 (fi) Heterocykliska foereningar
CA2159817A1 (en) Pyrimidine Acyclonucleoside Derivatives
ATE9336T1 (de) 3,1-benzoxazin-2-one, ihre herstellung und verwendung.
SE8503415L (sv) Nya isoindolinylalkylpiperaziner och farmaceutiska kompositioner innehallande desamma
ES8502703A1 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
SE8203877L (sv) Aminosulfonylbensoesyraderivat
ATE27158T1 (de) 2-imidazolylmethyl-2-phenyl-1,3-dioxolane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide.
ES2129073T3 (es) Derivados del acido 4-fenilcarbamoil-3-isoxazol-carboxilico con actividad antiinflamatoria.
AU590030B2 (en) Antihypertensive combination product
SE8203878D0 (sv) Antiviruskomposition
DK624989D0 (da) Hidtil ukendte forbindelser
MY102094A (en) A vinyl or ethynyl substituted aralkyl aryl compound for use as an insecticide/acaricide.
IE812146L (en) Ethenylimidazole derivatives
IL74921A0 (en) 4-(nitrophenyl)-tetrahydropyridines,their preparation and pharmaceutical compositions containing them
ES425939A1 (es) Metodo para controlar las malezas del campo mediante el em-pleo de un herbicida de tiocarmabato.
SE7908940L (sv) Nya acyl-1h-1,2,4-triazolderivat
DK599486A (da) 1,4-dihydropyridiner, deres fremstilling af anvendelse som laegemidler
MY103631A (en) Certain insecticidal 6-(phenoxy-2-pyridyl)-methyl-neo-phental ethers
ES8704947A1 (es) Un procedimiento para preparar un derivado de imidazopirida-zina
JPS57212111A (en) Second agent composition for permanent wave

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8203878-7

Format of ref document f/p: F